Colossal Biosciences Advances Bluebuck De-Extinction Effort
Digest more
Tru Niagen is expanding its patented nicotinamide riboside, known as Niagen, into skincare and beauty supplements. Driven by consumer demand, Niagen Bioscience’s leadership in N
Chinedu Agwu shares advice on supporting first-year students to develop the core skills and knowledge they need to succeed in a bioscience course In the past couple of years pre- and post-pandemic, university teaching staff have found that some students ...
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation in the International Society for Cell & Gene Therapy (ISCT) 2026 Annual Meeting to be held in Dublin,
In a recent interview, Robert Fried, CEO of Niagen Bioscience, delves into the science of aging and the pivotal role of a molecule known as NAD (nicotinamide adenine dinucleotide). He explains how NAD is crucial for cellular energy and repair, and how its ...
Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics. Drift back in time to that summer between high school and ...
LUND, SE / ACCESS Newswire / April 28, 2026 / Alligator Bioscience (STO:ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs, will publish its interim report for the period 1 January - 31 March 2026
A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the early-phase Bend Bioscience, along with the private equity manager ...
Investor's Business Daily on MSN
Twist Bioscience scores relative strength rating upgrade
Twist Bioscience shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Twist Bioscience Corp is set to report fiscal second-quarter results on Monday, May 4, before the market opens, as investors scrutinize whether the synthetic DNA manufacturer can sustain its momentum toward profitability.
Two startup bioscience companies backed by well-known local entrepreneurs have signed leases for space in the new Elm City Bioscience Center. The Hurley Group, owner and manager of the center, which is at 55 Church St., New Haven, announced Tuesday that it ...
View Twist Bioscience Corp. TWST stock quote prices, financial information, real-time forecasts, and company news from CNN.